324 related articles for article (PubMed ID: 21367833)
1. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.
Matsa E; Rajamohan D; Dick E; Young L; Mellor I; Staniforth A; Denning C
Eur Heart J; 2011 Apr; 32(8):952-62. PubMed ID: 21367833
[TBL] [Abstract][Full Text] [Related]
2. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.
Ma D; Wei H; Zhao Y; Lu J; Li G; Sahib NB; Tan TH; Wong KY; Shim W; Wong P; Cook SA; Liew R
Int J Cardiol; 2013 Oct; 168(6):5277-86. PubMed ID: 23998552
[TBL] [Abstract][Full Text] [Related]
3. Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
El-Battrawy I; Lan H; Cyganek L; Zhao Z; Li X; Buljubasic F; Lang S; Yücel G; Sattler K; Zimmermann WH; Utikal J; Wieland T; Ravens U; Borggrefe M; Zhou XB; Akin I
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29574456
[TBL] [Abstract][Full Text] [Related]
4. Targeted activation of human ether-à-go-go-related gene channels rescues electrical instability induced by the R56Q+/- long QT syndrome variant.
Venkateshappa R; Hunter DV; Muralidharan P; Nagalingam RS; Huen G; Faizi S; Luthra S; Lin E; Cheng YM; Hughes J; Khelifi R; Dhunna DP; Johal R; Sergeev V; Shafaattalab S; Julian LM; Poburko DT; Laksman Z; Tibbits GF; Claydon TW
Cardiovasc Res; 2023 Nov; 119(15):2522-2535. PubMed ID: 37739930
[TBL] [Abstract][Full Text] [Related]
5. Cross - site comparison of excitation-contraction coupling using impedance and field potential recordings in hiPSC cardiomyocytes.
Bot CT; Juhasz K; Haeusermann F; Polonchuk L; Traebert M; Stoelzle-Feix S
J Pharmacol Toxicol Methods; 2018; 93():46-58. PubMed ID: 29940218
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.
Crotti L; Neves R; Dagradi F; Musu G; Giannetti F; Bos JM; Barbieri M; Cerea P; Giovenzana FLF; Torchio M; Mura M; Gnecchi M; Conte G; Auricchio A; Sala L; Odening KE; Ackerman MJ; Schwartz PJ
Circulation; 2024 Jun; ():. PubMed ID: 38939955
[TBL] [Abstract][Full Text] [Related]
7. Long QT Syndrome
Feng L; Zhang J; Lee C; Kim G; Liu F; Petersen AJ; Lim E; Anderson CL; Orland KM; Robertson GA; Eckhardt LL; January CT; Kamp TJ
Circ Arrhythm Electrophysiol; 2021 Apr; 14(4):e009343. PubMed ID: 33729832
[TBL] [Abstract][Full Text] [Related]
8. A mathematical model of hiPSC cardiomyocytes electromechanics.
Forouzandehmehr M; Koivumäki JT; Hyttinen J; Paci M
Physiol Rep; 2021 Nov; 9(22):e15124. PubMed ID: 34825519
[TBL] [Abstract][Full Text] [Related]
9. [Pregnancy Management in a Patient with Long QT Syndrome Type 2 (LQT2) carrier of the variant KCNH2: Trp100X].
Hametner G; Osranek M; Brunckhorst C; Domingo AM
Praxis (Bern 1994); 2024 Feb; 113(2):50-54. PubMed ID: 38536194
[TBL] [Abstract][Full Text] [Related]
10. A biomimetic ion channel shortens the QT interval of type 2 long QT syndrome through efficient transmembrane transport of potassium ions.
Sun S; Xu Z; Lin Z; Chen W; Zhang Y; Yan M; Ren S; Liu Q; Zhu H; Tian B; Zhang J; Zhang W; Jiang S; Sheng C; Ge J; Chen F; Dong Z
Acta Biomater; 2024 Jun; 181():391-401. PubMed ID: 38704114
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome and open chromatin analysis reveals the process of myocardial cell development and key pathogenic target proteins in Long QT syndrome type 7.
Chen P; Long J; Hua T; Zheng Z; Xiao Y; Chen L; Yu K; Wu W; Zhang S
J Transl Med; 2024 Mar; 22(1):307. PubMed ID: 38528561
[TBL] [Abstract][Full Text] [Related]
12. Human-induced pluripotent stem cell-derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogs.
Gomez-Galeno J; Okolotowicz K; Johnson M; McKeithan WL; Mercola M; Cashman JR
Pharmacol Res Perspect; 2021 Aug; 9(4):e00828. PubMed ID: 34327875
[TBL] [Abstract][Full Text] [Related]
13. Proof of concept for monoclonal antibody therapy in a cellular model of acquired long QT syndrome type 3.
Kis L; Li J
Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H89-H95. PubMed ID: 37947435
[TBL] [Abstract][Full Text] [Related]
14. A greedy classifier optimization strategy to assess ion channel blocking activity and pro-arrhythmia in hiPSC-cardiomyocytes.
Raphel F; De Korte T; Lombardi D; Braam S; Gerbeau JF
PLoS Comput Biol; 2020 Sep; 16(9):e1008203. PubMed ID: 32976482
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological Changes in the Rabbit Ventricular Wedge and Human-Induced Pluripotent Stem-Cell Derived (IPSC) Cardiomyocytes Translate to Severe Arrhythmia Observed in a Canine Toxicology Study, Not Predicted by Standard In Vitro Ion Channel Assays.
Brown AP; Friedrichs GS; Tang HM; Traebert M; Weber V; Yao N; Yan GX
Int J Toxicol; 2024; 43(3):231-242. PubMed ID: 38327194
[TBL] [Abstract][Full Text] [Related]
16. Impaired Ca
Bamgboye MA; Traficante MK; Owoyemi J; DiSilvestre D; Vieira DCO; Dick IE
J Mol Cell Cardiol; 2022 Dec; 173():92-100. PubMed ID: 36272554
[TBL] [Abstract][Full Text] [Related]
17. Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy.
Moreau A; Reisqs JB; Delanoe-Ayari H; Pierre M; Janin A; Deliniere A; Bessière F; Meli AC; Charrabi A; Lafont E; Valla C; Bauer D; Morel E; Gache V; Millat G; Nissan X; Faucherre A; Jopling C; Richard S; Mejat A; Chevalier P
Clin Transl Med; 2021 Mar; 11(3):e319. PubMed ID: 33784018
[TBL] [Abstract][Full Text] [Related]
18. Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes.
Lapp H; Bruegmann T; Malan D; Friedrichs S; Kilgus C; Heidsieck A; Sasse P
Sci Rep; 2017 Aug; 7(1):9629. PubMed ID: 28851973
[TBL] [Abstract][Full Text] [Related]
19. Studying Long QT Syndrome Caused by
Belbachir N; Wu Y; Shen M; Zhang SL; Zhang JZ; Liu C; Knollmann BC; Lyon GJ; Ma N; Wu JC
Circulation; 2023 Nov; 148(20):1598-1601. PubMed ID: 37956223
[No Abstract] [Full Text] [Related]
20. Unexpected impairment of
Porta-Sánchez A; Mazzanti A; Tarifa C; Kukavica D; Trancuccio A; Mohsin M; Zanfrini E; Perota A; Duchi R; Hernandez-Lopez K; Jáuregui-Abularach ME; Pergola V; Fernandez E; Bongianino R; Tavazzani E; Gambelli P; Memmi M; Scacchi S; Pavarino LF; Franzone PC; Lentini G; Filgueiras-Rama D; Galli C; Santiago DJ; Priori SG
Nat Cardiovasc Res; 2023; 2(12):1291-1309. PubMed ID: 38665938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
